JP2002501535A - 選択結合性超音波造影剤 - Google Patents

選択結合性超音波造影剤

Info

Publication number
JP2002501535A
JP2002501535A JP50084899A JP50084899A JP2002501535A JP 2002501535 A JP2002501535 A JP 2002501535A JP 50084899 A JP50084899 A JP 50084899A JP 50084899 A JP50084899 A JP 50084899A JP 2002501535 A JP2002501535 A JP 2002501535A
Authority
JP
Japan
Prior art keywords
composition
biomolecule
lipid
microbubble shell
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50084899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501535A5 (https=
Inventor
クリバノフ，アレキサンダー・エイ
ライル，レオン・アール
トーマス，エム・エリザベス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of JP2002501535A publication Critical patent/JP2002501535A/ja
Publication of JP2002501535A5 publication Critical patent/JP2002501535A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP50084899A 1997-05-27 1998-05-27 選択結合性超音波造影剤 Pending JP2002501535A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/863,647 US6245318B1 (en) 1997-05-27 1997-05-27 Selectively binding ultrasound contrast agents
US08/863,647 1997-05-27
PCT/US1998/010745 WO1998053857A1 (en) 1997-05-27 1998-05-27 Selectively binding ultrasound contrast agents

Publications (2)

Publication Number Publication Date
JP2002501535A true JP2002501535A (ja) 2002-01-15
JP2002501535A5 JP2002501535A5 (https=) 2005-12-08

Family

ID=25341485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50084899A Pending JP2002501535A (ja) 1997-05-27 1998-05-27 選択結合性超音波造影剤

Country Status (6)

Country Link
US (1) US6245318B1 (https=)
EP (1) EP0988062A4 (https=)
JP (1) JP2002501535A (https=)
AU (1) AU7600798A (https=)
CA (1) CA2288013A1 (https=)
WO (1) WO1998053857A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521338A (ja) * 2004-01-07 2007-08-02 アンビット バイオサイエンシス コーポレーション 共役化された低分子
JP2009529668A (ja) * 2006-03-10 2009-08-20 マギル ユニバーシティー 超音波分子センサーおよびその使用
JP2016503783A (ja) * 2012-12-21 2016-02-08 シェミン イェ，ジェームズ 微粒子組成物

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261537B1 (en) * 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
US6331289B1 (en) 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US20070036722A1 (en) * 1996-10-28 2007-02-15 Pal Rongved Separation processes
WO1999013918A2 (en) * 1997-09-18 1999-03-25 University Of Pittsburgh Icam-1 selective echogenic microbubbles
CA2727746A1 (en) * 1998-12-18 2000-06-22 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6306132B1 (en) 1999-06-17 2001-10-23 Vivant Medical Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use
AU2001263762A1 (en) * 2000-05-02 2001-11-12 Hahn-Meitner-Institut Berlin Gmbh Molecular arrangement with a structural configuration and use thereof for quantum-mechanical information processing
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
AU2001266696A1 (en) 2000-06-02 2001-12-11 Bracco Research Usa Compounds for targeting endothelial cells
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
US6878147B2 (en) 2001-11-02 2005-04-12 Vivant Medical, Inc. High-strength microwave antenna assemblies
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
US7985402B2 (en) * 2002-03-01 2011-07-26 Bracco Suisse Sa Targeting vector-phospholipid conjugates
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US20050250700A1 (en) * 2002-03-01 2005-11-10 Sato Aaron K KDR and VEGF/KDR binding peptides
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
CA2666005C (en) 2002-03-01 2016-01-19 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US20050100963A1 (en) * 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7666979B2 (en) * 2002-03-01 2010-02-23 Bracco International B.V. Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US6752767B2 (en) 2002-04-16 2004-06-22 Vivant Medical, Inc. Localization element with energized tip
US7197363B2 (en) 2002-04-16 2007-03-27 Vivant Medical, Inc. Microwave antenna having a curved configuration
AU2003251858A1 (en) * 2002-07-11 2004-02-02 Targeson, Llc Microbubble compositions, and methods for preparing and using same
EP2290100B1 (en) * 2002-11-01 2014-02-19 Iris International, Inc. Kits for displacement Sandwich Immuno-PCR
CA2509248A1 (en) 2002-12-31 2004-07-22 Nektar Therapeutics Al, Corporation Polymeric reagents comprising a ketone or a related functional group
US7141612B2 (en) * 2002-12-31 2006-11-28 3M Innovative Properties Company Stabilized foams including surface-modified organic molecules
US7129277B2 (en) * 2002-12-31 2006-10-31 3M Innovative Properties Company Emulsions including surface-modified inorganic nanoparticles
US7001580B2 (en) * 2002-12-31 2006-02-21 3M Innovative Properties Company Emulsions including surface-modified organic molecules
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7462703B2 (en) * 2003-01-31 2008-12-09 Max-Delbruck-Centrum Fur Molekulare Medizin Agent for gene transfer
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
JP4670083B2 (ja) * 2003-02-04 2011-04-13 ブラッコ・シュイス・ソシエテ・アノニム 超音波造影剤およびその製造方法
PT2949658T (pt) 2003-03-03 2018-10-18 Bracco Suisse Sa Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
US7311703B2 (en) 2003-07-18 2007-12-25 Vivant Medical, Inc. Devices and methods for cooling microwave antennas
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
US9248204B2 (en) * 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
AU2005292083A1 (en) * 2004-09-29 2006-04-13 Alza Corporation Microparticles and nanoparticles containing a lipopolymer
DE602005023529D1 (de) * 2004-11-03 2010-10-21 Iris Molecular Diagnostics Inc Homogener nachweis von analyten
CN103091485A (zh) * 2004-11-03 2013-05-08 艾瑞斯国际有限公司 用于亲和分离的微泡
US20060140867A1 (en) * 2004-12-28 2006-06-29 Helfer Jeffrey L Coated stent assembly and coating materials
US8257338B2 (en) * 2006-10-27 2012-09-04 Artenga, Inc. Medical microbubble generation
JP5242408B2 (ja) 2005-12-09 2013-07-24 ブラッコ・スイス・ソシエテ・アノニム ターゲットベクター・リン脂質コンジュゲート
US8068921B2 (en) 2006-09-29 2011-11-29 Vivant Medical, Inc. Microwave antenna assembly and method of using the same
US8293214B2 (en) 2006-12-19 2012-10-23 Bracco Suisse S.A. Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
US8292880B2 (en) 2007-11-27 2012-10-23 Vivant Medical, Inc. Targeted cooling of deployable microwave antenna
CN103884840A (zh) * 2008-02-21 2014-06-25 艾瑞斯国际有限公司 早期确定前列腺癌治疗后复发的方法
MX2010012473A (es) 2008-05-23 2011-02-23 Siwa Corp Metodos, composiciones y aparato para facilitar la regeneracion.
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
WO2010042815A2 (en) * 2008-10-09 2010-04-15 Duke University Vhh antibody fragments for use in the detection and treatment of cancer
EP2470287A4 (en) 2009-08-28 2015-01-21 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR PRODUCING GAS-FILLED MICROBUBBLES
WO2011028690A1 (en) 2009-09-01 2011-03-10 The Trustees Of Columbia University In The City Of New York Microbubble devices, methods and systems
US8518405B2 (en) 2009-10-08 2013-08-27 The University Of North Carolina At Charlotte Tumor specific antibodies and uses therefor
EP2345732A1 (en) 2010-01-19 2011-07-20 Universite Paris Descartes Methods for intracellular delivery of nucleic acids
BR112013002945A2 (pt) 2010-08-09 2016-06-07 Inst Nat Sante Rech Med composição farmacâutica formulada com agente de eco-contraste de microbolhas e um ácido nucleico terapêutico de interesse para uso em um método para tratamento de uma doença ocular em um sujeito
US9649376B2 (en) 2010-09-27 2017-05-16 Siwa Corporation Selective removal of age-modified cells for treatment of atherosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
EP2748299B1 (en) 2011-08-24 2018-03-14 The Regents of The University of California Targeting microbubbles
WO2014065513A1 (ko) * 2012-10-25 2014-05-01 서강대학교 산학협력단 약물을 함유한 나노입자가 결합된 초음파 조영제 및 이의 제조방법
US10471163B2 (en) 2013-09-13 2019-11-12 The General Hospital Corporation Activatable fibrin-binding probes
WO2015198153A2 (en) 2014-01-28 2015-12-30 Targeson, Inc. Isolation of cells and biological substances using buoyant microbubbles
WO2015134671A1 (en) 2014-03-04 2015-09-11 Targeson, Inc. Molecular imaging contrast agents and uses thereof
JP6557681B2 (ja) 2014-05-10 2019-08-07 ダイアグノロジックス・エルエルシー 浮力を用いて薬剤を単離または濃縮するためのシステムおよび装置
AU2015292498B2 (en) 2014-07-23 2020-11-05 Ohio State Innovation Foundation Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
CN107001459B (zh) 2014-09-19 2021-11-23 Siwa有限公司 用于治疗炎症和自身免疫紊乱的抗age抗体
US10052394B2 (en) 2014-11-21 2018-08-21 General Electric Company Microbubble tether for diagnostic and therapeutic applications
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
WO2016118947A1 (en) 2015-01-23 2016-07-28 The University Of North Carolina At Chapel Hill Apparatuses, systems, and methods for preclinical ultrasound imaging of subjects
EP3310794B1 (en) 2015-06-18 2025-08-06 California Institute of Technology Synthesis and application of microbubble-forming compounds
PT3337829T (pt) 2016-02-19 2020-02-10 Siwa Corp Método e composição para o tratamento do cancro, matando células cancerosas metastáticas e prevenindo as metástases do cancro usando anticorpos para produtos finais de glicação avançada (pga)
CA3057829A1 (en) 2016-04-15 2017-10-19 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
WO2017222535A1 (en) 2016-06-23 2017-12-28 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
CA3059803A1 (en) 2017-04-13 2018-10-18 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications
US12150813B2 (en) 2019-05-10 2024-11-26 The University Of North Carolina At Chapel Hill Methods, systems, and computer readable media for generating super-resolution images of microvasculature using ultrasound
CN114364383A (zh) * 2019-06-05 2022-04-15 微脉管治疗有限公司 检测和治疗血栓形成和血管斑块的组合物和方法
US10953023B1 (en) 2020-01-28 2021-03-23 Applaud Medical, Inc. Phospholipid compounds and formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853228A (en) * 1987-07-28 1989-08-01 Micro-Pak, Inc. Method of manufacturing unilamellar lipid vesicles
US5620689A (en) * 1989-10-20 1997-04-15 Sequus Pharmaceuuticals, Inc. Liposomes for treatment of B-cell and T-cell disorders
US5656211A (en) * 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
IN172208B (https=) * 1990-04-02 1993-05-01 Sint Sa
BR9405798A (pt) * 1993-02-22 1995-12-12 Vivorx Pharmaceuticals Inc Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
EP0727225A3 (en) * 1995-02-14 1997-01-15 Sonus Pharma Inc Compositions and methods for directed ultrasonic imaging
CA2218541A1 (en) * 1995-06-07 1996-12-19 Imarx Pharmaceutical Corp. Novel targeted compositions for diagnostic and therapeutic use
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
GB9622368D0 (en) 1996-10-28 1997-01-08 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
EP0973552B1 (en) * 1996-10-28 2006-03-01 Amersham Health AS Improvements in or relating to diagnostic/therapeutic agents
GB9708265D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521338A (ja) * 2004-01-07 2007-08-02 アンビット バイオサイエンシス コーポレーション 共役化された低分子
JP2009529668A (ja) * 2006-03-10 2009-08-20 マギル ユニバーシティー 超音波分子センサーおよびその使用
JP2016503783A (ja) * 2012-12-21 2016-02-08 シェミン イェ，ジェームズ 微粒子組成物
CN109999206A (zh) * 2012-12-21 2019-07-12 叶学明 微粒组合物

Also Published As

Publication number Publication date
EP0988062A4 (en) 2003-04-23
AU7600798A (en) 1998-12-30
WO1998053857A1 (en) 1998-12-03
CA2288013A1 (en) 1998-12-03
EP0988062A1 (en) 2000-03-29
US6245318B1 (en) 2001-06-12

Similar Documents

Publication Publication Date Title
JP2002501535A (ja) 選択結合性超音波造影剤
JP2001511765A (ja) 改良された診断／治療用薬剤
EP1073475B1 (en) Improvements in or relating to diagnostic/therapeutic agents
US8293214B2 (en) Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
JP2001503407A (ja) 改良された診断／治療用薬剤
US6548048B1 (en) Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
US20030044354A1 (en) Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
CN103079599B (zh) 靶向气体填充微囊
US20050260189A1 (en) Microbubble compositions, and methods for preparing and using same
CN101374955B (zh) 靶向载体-磷脂缀合物
JP2001506587A (ja) 安定微粒子および超音波コントラスト剤としてのその使用
JP2005505532A (ja) 気体微粒子リポソーム複合体
WO1999013918A2 (en) Icam-1 selective echogenic microbubbles
Klibanov Molecular imaging with targeted ultrasound contrast microbubbles
JP2001502719A (ja) 改良された診断／治療用薬剤
JP2002515889A (ja) 改良された診断／治療用薬剤
AU2001288274A1 (en) Gas microsphere lipsome composites

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050525

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050525

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080527

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080819

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081209

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090219

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090609